Remove 2009 Remove Clinical Trials Remove Marijuana Remove Safety
article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

Are you able to answer your patients’ medical marijuana questions? During my tenure, I have found the medical marijuana educational gap to be one of the most significant educational gaps that impacts a very broad range of healthcare providers. million medical marijuana patients nationwide.

article thumbnail

Cannabis Industry Leaders Speak With CLR on Current Delta 8 Issues In The Industry

Cannabis Law Report

Dr Stuart Titus the CEO at Medical Marijuana Inc. is an industry innovator who has been involved in the growth of many companies in the cannabis industry, and started his relationship with Medical Marijuana Inc. His first-hand experience with therapeutic hemp oil products as nutritional supplements led him to Medical Marijuana Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Article: Canada: Future Care Costs For Cannabis In Personal Injury Claims

Cannabis Law Report

Given the controversy over the efficacy and safety of cannabis for therapeutic purposes, a key question in these cases, is whether cannabis meets the requirement of medical justification. An award for marijuana was allowed in this case, which involved a negligence claim against a surgeon.

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Members of Congress voiced support for marijuana/AIDS research. Rick Doblin, Ph.D., and Michael Mithoefer, M.D.,

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The search terms used were as follows: “medicinal cannabis”; “cannabis”; “marijuana”; “medic* marijuana”; and “medic* cannabis”.

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement. Wakshlag, DVM, Ph.D.,

Safety 45
article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009.